The brain on drugs: Defining the neural anatomy and physiology of morphine on dopamine neurons

October 4, 2011 by Stuart Mason Dambrot, Medical Xpress feature
tVTA/RMTg efferents in the VTA express μORs. (A) Microphotographs illustrating the GAD67 and μOR double labeling in the tVTA/RMTg at a cellular level. GAD67, glutamic acid decarboxylase 67 kDa. (B) Following BDA injection into tVTA/RMTg (Left), μORs were detected within anterogradely labeled axons in the VTA (Right). (C) Following CTb injection into VTA (Left), μORs were observed in retrogradely labeled cell bodies in the tVTA/RMTg (Right). fr, fasciculus retroflexus; IF, interfascicular nucleus; ml, medial lemniscus; RLi, rostral linear nucleus of the raphe; tth, trigeminothalamic tract; xscp, superior cerebellar peduncle decussation. (c) PNAS, doi:10.1073/pnas.1105418108

(Medical Xpress) -- Morphine's analgesic properties are as potent as its addictive potential are problematic. The neural pathway for that addiction is typically associated with dopamine (DA) neurons of the ventral tegmental area (VTA), despite the fact that the specific neuronal mechanisms involved are not well articulated. Recently, however, research conducted at the Université de Bordeaux and Université de Strasbourg in France found that morphine increases the firing of dopamine neurons by activating μ opioid receptor (μOR) receptors on the rostromedial tegmental nucleus (the VTA's GABAergic tail) – and that there is no morphine-induced activation of dopamine neurons in the absence of tonic VTA glutamatergic modulation.

The lead researcher, Marion Jalabert, Dr François Georges, and the multidisciplinary research team used in vivo electrophysiology, tract-tracing experiments, and targeted neuronal inactivation to successfully capture activity in dopaminergic rat . The project was made possible by collaboration between two groups with their own domain of expertise – in vivo electrophysiology by Georges’ team in Bordeaux and neuroanatomy by Michel Barrot’s group in Strasbourg.

The main challenge they faced, notes Georges, was to work in an intact in vivo preparation in order to dissect the neuronal circuit responsible for the excitatory effect of morphine on . “To test our hypothesis that morphine will disrupt the excitatory/inhibitory balance in dopamine neurons we had to pharmacologically disconnect two closely-located brain structures. Another challenge,” he continues, “was to identify the molecular target of morphine onto the GABAergic tVTA/RMTg terminals innervating the VTA.”

To address these challenges, Georges explains, the groups had to develop highly-targeted drug application methods to be able to record in vivo activity of dopamine neurons and at the same time apply drugs in their vicinity – something made possible by the use of double-barrel pipette. “The key insight,” he adds, “was to preserve the integrity of the neuronal network.”

Georges identifies the next innovation to be developed and applied to the current experimental design as the use of optogenetic approaches to be able to activate or inhibit on demand the population of tVTA/RMTg neurons projecting to the VTA. Moreover, he points out, “This optogenetic approach could be coupled to electrophysiological recordings in freely moving animals. This will allow us to evaluate the impact of the context on the excitatory effect of morphine on dopamine neurons.”

Another innovative step will be developing virtual models. “Based on our findings and the previous in vitro findings obtained in 1992 by Johnson and North, it will be possible and really interesting to elaborate a computational model of the impact of morphine on the regulation of dopamine neuron excitability properties. This in silico approach will help to predict the effect of various drugs of abuse on the dopamine neurons depending on their excitability state.”

In terms of substance-dependence prevention and treatment, Georges cites the morphine-induced excitation of dopamine neurons that resulted from simultaneous NMDA/AMPA receptor activation and cessation of GABA receptor activation. “Our findings suggest that the intrinsic excitability of VTA-DA neurons may be important for scaling morphine responses.” Given that morphine has a high addictive potential in specific contexts, this indicates that the excitatory context of dopamine neurons may tune the addictive potency of morphine.

“Our research,” Georges stresses, “is currently focusing on understanding how the context and the history of the animal” – that is, exposure to stress or to other drugs of abuse tune in vivo the intrinsic excitability of VTA-DA neurons – “may be important for scaling morphine responses.”

Georges also sees their research having implications for a range of medical applications. “Our study,” he concludes, “provides a better understanding of tVTA/RMTg neurophysiology. The impact of this newly discovered brain area on dopamine neurons may provide new neuroanatomical targets for treatment. This neuronal participates to the etiology of neurological and psychiatric diseases, such as , schizophrenia, mood disorders or Parkinson’s disease.”

Explore further: Nicotine and cocaine leave similar mark on brain after first contact

More information: Neuronal circuits underlying acute morphine action on dopamine neurons. Published online before print September 19, 2011, doi: 10.1073/pnas.1105418108, PNAS September 27, 2011 vol. 108 no. 39 16446-16450

Related: Opioids excite dopamine neurons by hyperpolarization of local interneurons. SW Johnson and RA North, The Journal of Neuroscience, 1 February 1992, 12(2): 483-488


Related Stories

Nicotine and cocaine leave similar mark on brain after first contact

May 3, 2011
The effects of nicotine upon brain regions involved in addiction mirror those of cocaine, according to new neuroscience research.

Sniffing out Parkinson's

September 23, 2011
A team of neuroscientists in UConn's College of Liberal Arts and Sciences has mapped the brain’s nerve connections that help control the sense of smell, which could add another brain region to the list of those affected ...

Recommended for you

Research reveals atomic-level changes in ALS-linked protein

January 18, 2018
For the first time, researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases ...

Fragile X finding shows normal neurons that interact poorly

January 18, 2018
Neurons in mice afflicted with the genetic defect that causes Fragile X syndrome (FXS) appear similar to those in healthy mice, but these neurons fail to interact normally, resulting in the long-known cognitive impairments, ...

How your brain remembers what you had for dinner last night

January 17, 2018
Confirming earlier computational models, researchers at University of California San Diego and UC San Diego School of Medicine, with colleagues in Arizona and Louisiana, report that episodic memories are encoded in the hippocampus ...

Recording a thought's fleeting trip through the brain

January 17, 2018
University of California, Berkeley neuroscientists have tracked the progress of a thought through the brain, showing clearly how the prefrontal cortex at the front of the brain coordinates activity to help us act in response ...

Midbrain 'start neurons' control whether we walk or run

January 17, 2018
Locomotion comprises the most fundamental movements we perform. It is a complex sequence from initiating the first step, to stopping when we reach our goal. At the same time, locomotion is executed at different speeds to ...

Neuroscientists suggest a model for how we gain volitional control of what we hold in our minds

January 16, 2018
Working memory is a sort of "mental sketchpad" that allows you to accomplish everyday tasks such as calling in your hungry family's takeout order and finding the bathroom you were just told "will be the third door on the ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

5 / 5 (1) Oct 13, 2011
I have been on morphine on a few occasions in the hospital. This article completely supports my experiences--you feel really happy and relaxed. It's no wonder people have gotten addicted. I hate however that people abuse drugs like this; I have gone through seven surgeries (clearly needing pain medicine) and have gotten off them, yet I see people who do NOT require medication abusing the system for a fix. Very sad.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.